Data backs durability of Medtronic CoreValve Evolut TAVR
Medtronic today announced five-year data that supports its CoreValve Evolut transcatheter aortic valve replacement (TAVR) implant.
Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic today announced five-year data that supports its CoreValve Evolut transcatheter aortic valve replacement (TAVR) implant.
Harmony Transcatheter Pulmonary Valve System is the first FDA-approved minimally invasive valve designed for the right side of the heartÂ
Ryan Weispfenning: Good morning. I am Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations. Welcome to Minnesota where signs of spring are in the air.
/PRNewswire/ -- Transmural Systems the leader in transcatheter electrosurgery for structural interventions announced today successful first-in-human procedure...
MDT earnings call for the period ending December 31, 2022.